# See Cheng Yeo

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/see-cheng-yeo/

## Facts

| Field | Value |
| --- | --- |
| Citations | 929 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 16 |
| i10-index | 19 |
| Last Known Institution | University of Leicester |
| OpenAlex ID | https://openalex.org/A5062052086 |
| ORCID iD | 0000-0003-0857-4781 |
| Works | 52 |

## Researcher papers

- [New insights into the pathogenesis of IgA nephropathy](https://scholariq.org/papers/new-insights-into-the-pathogenesis-of-iga-nephropathy/)
- [Is immunoglobulin A nephropathy different in different ethnic populations?](https://scholariq.org/papers/is-immunoglobulin-a-nephropathy-different-in-different-ethnic-populations/)
- [Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial](https://scholariq.org/papers/design-and-baseline-characteristics-of-the-finerenone-in-addition-to-standard-of/)
- [Cost-effectiveness of screening for chronic kidney disease in the general adult population: a systematic review](https://scholariq.org/papers/cost-effectiveness-of-screening-for-chronic-kidney-disease-in-the-general-adult/)
- [Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial](https://scholariq.org/papers/phase-2-trial-of-cemdisiran-in-adult-patients-with-iga-nephropathy-a-randomized/)
- [Risk Factors for Development of Acute Kidney Injury in COVID-19 Patients: A Retrospective Observational Cohort Study](https://scholariq.org/papers/risk-factors-for-development-of-acute-kidney-injury-in-covid-19-patients-a/)
- [The contribution of a proliferation-inducing ligand (APRIL) and other TNF superfamily members in pathogenesis and progression of IgA nephropathy](https://scholariq.org/papers/the-contribution-of-a-proliferation-inducing-ligand-april-and-other-tnf/)
- [An Update on Current Therapeutic Options in IgA Nephropathy](https://scholariq.org/papers/an-update-on-current-therapeutic-options-in-iga-nephropathy/)
- [The solution structures of native and patient monomeric human IgA1 reveal asymmetric extended structures: implications for function and IgAN disease](https://scholariq.org/papers/the-solution-structures-of-native-and-patient-monomeric-human-iga1-reveal/)
- [Ensuring Sustainability of Continuous Kidney Replacement Therapy in the Face of Extraordinary Demand: Lessons From the COVID-19 Pandemic](https://scholariq.org/papers/ensuring-sustainability-of-continuous-kidney-replacement-therapy-in-the-face-of/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)

## Researcher university

- [University of Leicester](https://scholariq.org/institutions/university-of-leicester/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.